Has Zahf Shaikh received payments from drug or device companies?

Yes. Drug and device makers reported $3,698 in general payments to Zahf Shaikh across 97 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Zahf Shaikh did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Zahf Shaikh come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Zahf Shaikh

Internal Medicine · Hackensack, NJNPI 1366976433

Payments from drug & device makers

$3,698in general payments, 2019–2025

Across 97 payments — averaging $38.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Madrigal Pharmaceuticals$723
Gilead$393
Takeda Pharmaceuticals U.S.A., Inc.$358
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$351
AbbVie$296
Ardelyx, Inc.$278
plus $1K from 13 others

What the payments were for

Food & beverage$3,698100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Madrigal Pharmaceuticals	24	$723
Gilead	7	$393
Takeda Pharmaceuticals U.S.A., Inc.	17	$358
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	3	$351
AbbVie	6	$296
Ardelyx, Inc.	10	$278
Intra-sana Laboratories	2	$223
QOL Medical, LLC	6	$214
Mallinckrodt Hospital Products Inc.	2	$154
Phathom Pharmaceuticals, Inc.	4	$146
E.r. Squibb & Sons, L.L.C.	1	$125
Ipsen Biopharmaceuticals, Inc	5	$120
Johnson & Johnson	1	$109
Sanofi	4	$101
Regeneron Healthcare Solutions, Inc.	1	$38
Celltrion USA Inc.	1	$19
Capsovision, Inc.	1	$18
Pfizer	1	$17
Intercept Pharmaceuticals, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,698 in reported general payments places this provider in the 85th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates	12	$754
Pantoprazole Sodium	27	$252

Paid to pharmacies, not to this prescriber.

Other internal medicine in Hackensack

Suhel AhmedHackensack$82K
Sanjiv SharmaToms River$33.9M
Jeffrey CarsonNew Brunswick$13.8M
Samer HaddadHamilton$6.8M
Magdy ShenoudaWall$3.7M
Samar HameedLivingston$3.6M
Jane RohlfTrenton$2.7M
Mohammed NisarEdison$2.6M
Michael CasserNew Milford$2.2M
Sumitha ReddyHamilton$2M

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →